trending Market Intelligence /marketintelligence/en/news-insights/trending/rq-_5m-xrkfob2xmrmubea2 content esgSubNav
In This List

Report: Nordic Capital withdraws bid for Sanofi's European generic drugs unit

Video

According to Market Intelligence, February 2023

Blog

Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


Report: Nordic Capital withdraws bid for Sanofi's European generic drugs unit

Nordic Capital Ltd. withdrew its bid to acquire Sanofi's European generic drugs unit due to high price expectations, the Financial Times reported, citing people familiar with the matter.

According to the sources, the European private equity firm was considering a team-up with U.S.-based Blackstone Group LP to acquire the unit, which Sanofi is looking to sell for up to €2 billion.

With Nordic Capital out, Advent International Corp., BC Partners Ltd. and Carlyle Group LP, as well as at least one pharma company, remain as bidders for the business, the Financial Times said.

The next deadline for bids is reportedly in April.